|
|
Kewaunee Scientific Corporation (NASDAQ: KEQU) |
|
|
|
KEQU's EPS from Cont. Operations Growth by Quarter and Year
Kewaunee Scientific's EPS from Cont. Operations results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
EPS from Cont. Operations Growth Y/Y▼
|
EPS from Cont. Operations Growth Y/Y▼
|
KEQU EPS from Cont. Operations (in $) |
FY 2025 |
FY 2024 |
FY 2023 |
FY 2022 |
4th Quarter |
April |
1.70
|
3.86
|
0.36
|
-0.13
|
3rd Quarter |
January |
0.47
|
0.87
|
0.26
|
-0.47
|
2nd Quarter |
October |
1.05
|
0.94
|
-0.09
|
-1.11
|
1st Quarter |
July |
0.77
|
0.87
|
-0.27
|
-0.48
|
FY |
|
3.99
|
6.54
|
0.26
|
-2.19
|
KEQU EPS from Cont. Operations fourth quarter 2025 Y/Y Growth Comment |
Kewaunee Scientific Corporation reported drop in EPS from Cont. Operations in the fourth quarter 2025 by -55.99% to $ 1.70 , from the same quarter in 2024. The fall in the fourth quarter 2025 Kewaunee Scientific Corporation's EPS from Cont. Operations compares unfavorably to the Company's average EPS from Cont. Operations jump of 42.89%.
Looking into fourth quarter 2025 results within Laboratory Analytical Instruments industry 2 other companies have achieved higher EPS from Cont. Operations growth. While Kewaunee Scientific Corporation' s EPS from Cont. Operations meltdown of -55.99% ranks overall at the positon no. 176 in the fourth quarter 2025.
|
KEQU EPS from Cont. Operations ( Y/Y Growth %) |
2025
|
2024 |
2023 |
2022 |
4th Quarter |
April |
-55.99 % |
972.22 % |
- |
- |
3rd Quarter |
January |
-45.98 % |
234.62 % |
- |
- |
2nd Quarter |
October |
11.7 % |
- |
- |
- |
1st Quarter |
July |
-11.49 % |
- |
- |
- |
FY |
|
-39.01 % |
2415.38 % |
- |
- |
KEQU EPS from Cont. Operations (Quarter on Quarter Growth %) |
2025
|
2024 |
2023 |
2022 |
4th Quarter |
April |
261.44 % |
343.68 % |
38.46 % |
- |
3rd Quarter |
January |
-55.24 % |
-7.45 % |
- |
- |
2nd Quarter |
October |
36.36 % |
8.05 % |
- |
- |
1st Quarter |
July |
-80.05 % |
141.67 % |
- |
- |
FY (Year on Year) |
|
-39.01 % |
2415.38 % |
- |
- |
EPS from Cont. Operations Y/Y Growth Statistics |
High |
Average |
Low |
2460.34 % |
42.89 % |
-1052.81 % |
(Apr 30 2024) |
|
(Jul 31 2020) |
|
EPS from Cont. Operations Y/Y Growth Statistics |
High |
Average |
Low |
2460.34 % |
42.89 % |
-1052.81 % |
(Apr 30 2024) |
|
(Jul 31 2020) |
|
EPS from Cont. Operations by Quarter for the Fiscal Years 2022, 2023, 2024, 2025 |
Kewaunee Scientific's Q/Q EPS from Cont. Operations Growth
EPS from Cont. Operations Q/Q Growth Statistics |
High |
Average |
Low |
343.13 % |
29.8 % |
-99.16 % |
(Apr 30 2024) |
|
|
KEQU's IV. Quarter Q/Q EPS from Cont. Operations Comment |
Kewaunee Scientific Corporation achieved in the IV. Quarter 2025 above company average sequential EPS from Cont. Operations doubling of 261.44%, to $ 1.70 , from $0.47 in the third quarter.
Within Laboratory Analytical Instruments industry Kewaunee Scientific Corporation achieved highest sequential EPS from Cont. Operations growth. While Kewaunee Scientific's EPS from Cont. Operations growth quarter on quarter, overall rank is 108. |
|
|
EPS from Cont. Operations Q/Q Growth Statistics |
High |
Average |
Low |
343.13 % |
29.8 % |
-99.16 % |
(Apr 30 2024) |
|
|
KEQU's IV. Quarter Q/Q EPS from Cont. Operations Comment |
Kewaunee Scientific Corporation achieved in the IV. Quarter 2025 above company average sequential EPS from Cont. Operations doubling of 261.44%, to $ 1.70 , from $0.47 in the third quarter.
Within Laboratory Analytical Instruments industry Kewaunee Scientific Corporation achieved highest sequential EPS from Cont. Operations growth. While Kewaunee Scientific's EPS from Cont. Operations growth quarter on quarter, overall rank is 108. |
|
Kewaunee Scientific's 12 Months EPS from Cont. Operations Growth Year on Year
EPS from Cont. Operations TTM Growth |
12 Months Ending (Apr 30 2025) |
12 Months Ending (Jan 31 2025) |
12 Months Ending (Oct 31 2024) |
12 Months Ending (Jul 31 2024) |
12 Months Ending (Apr 30 2024) |
Cumulative EPS from Cont. Operations 12 Months Ending |
$ 3.99 |
$ 6.15 |
$ 6.55 |
$ 6.44 |
$ 6.54 |
Y / Y EPS from Cont. Operations Growth (TTM) |
-38.97 % |
102.46 % |
169.88 % |
361.23 % |
2460.34 % |
Year on Year EPS from Cont. Operations Growth Overall
Ranking |
# 10 |
# 10 |
# 12 |
# 6 |
# 8 |
Seqeuential EPS from Cont. Operations Change (TTM) |
-35.09 % |
-6.11 % |
1.71 % |
-1.53 % |
115.31 % |
Seq. EPS from Cont. Operations Growth (TTM) Overall
Ranking |
# 176 |
# 478 |
# 258 |
# 47 |
# 42 |
Cumulative EPS from Cont. Operations growth Comment |
For the 12 months ended Apr 30 2025 Kewaunee Scientific reported a drop in EPS from Cont. Operations by -38.97% year on year, to $4 , compare to the 102.46% growth at Jan 31 2025.
Looking into Healthcare sector trailing twelve month EPS from Cont. Operations increase, only one company had higher growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. 10. |
|
|
EPS from Cont. Operations TTM Y/Y Growth Statistics |
High |
Average |
Low |
2460.34 % |
42.89 % |
-1052.81 % |
|
|
|
EPS from Cont. Operations TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 3 |
Sector |
# 21 |
S&P 500 |
# 176 |
|
Cumulative EPS from Cont. Operations growth
Comment |
For the 12 months ended Apr 30 2025 Kewaunee Scientific reported a drop in EPS from Cont. Operations by -38.97% year on year, to $4 , compare to the 102.46% growth at Jan 31 2025.
Looking into Healthcare sector trailing twelve month EPS from Cont. Operations increase, only one company had higher growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. 10. |
EPS from Cont. Operations TTM Y/Y Growth Statistics |
High |
Average |
Low |
2460.34 % |
42.89 % |
-1052.81 % |
|
|
|
EPS from Cont. Operations TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 3 |
Sector |
# 21 |
S&P 500 |
# 176 |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com